Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 455,731 | 442,626 | 402,472 | 327,117 | 166,555 |
| Marketable Securities | 364,645 | N/A | N/A | N/A | N/A |
| Receivables | 63,009 | 52,093 | 33,584 | 34,158 | 29,808 |
| Inventories | 5,446 | 4,501 | 692 | N/A | N/A |
| TOTAL | $929,864 | $528,820 | $473,977 | $361,275 | $196,363 |
| Non-Current Assets | |||||
| PPE Net | 10,092 | 9,215 | 7,833 | 12,299 | 17,660 |
| Investments And Advances | 0 | 0 | 0 | 0 | 996 |
| Other Non-Current Assets | 69,550 | 58,966 | 44,952 | 41,395 | 38,177 |
| TOTAL | $79,642 | $68,181 | $52,785 | $53,694 | $56,834 |
| Total Assets | $1,009,506 | $597,001 | $526,762 | $414,968 | $253,197 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,100 | 17,798 | 14,450 | 48,728 | 33,035 |
| Accrued Expenses | 185,534 | 119,835 | 76,747 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 33,675 | 140 |
| TOTAL | $212,181 | $139,021 | $100,835 | $84,129 | $70,617 |
| Non-Current Liabilities | |||||
| Long Term Debt | 391,013 | 48,011 | 47,807 | 51,190 | 47,064 |
| Deferred Revenues | N/A | N/A | 7,756 | N/A | N/A |
| Other Non-Current Liabilities | 40,162 | 35,611 | 33,975 | 78 | 177 |
| TOTAL | $436,609 | $89,137 | $87,024 | $94,945 | $111,515 |
| Total Liabilities | $648,790 | $228,158 | $187,859 | $179,074 | $182,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,068 | N/A | N/A | N/A | N/A |
| Common Shares | 135 | 134 | 129 | 121 | 1 |
| Retained earnings | -795,761 | -744,674 | -689,387 | -661,962 | -449,232 |
| Other shareholders' equity | -33,762 | -36,260 | -54,672 | 605,887 | 24,376 |
| TOTAL | $360,716 | $368,843 | $338,903 | $235,894 | $71,064 |
| Total Liabilities And Equity | $1,009,506 | $597,001 | $526,762 | $414,968 | $253,197 |